Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

551 - 560 of 3156 results found

Reviewing novel treatment options for carbapenem-resistant enterobacterales

Date
Saturday, January 06, 2024 - 4:00 AM
Description
INTRODUCTION: Carbapenem resistant Enterobacterales (CRE) are a major threat to global health and hospital-onset CRE infections have risen during the COVID-19 pandemic. Novel antimicrobials are now available for the treatment of CRE infections. There

Remdesivir: treatment of COVID-19 in special populations

Date
Friday, January 05, 2024 - 4:00 AM
Description
Remdesivir (RDV) is the mainstay antiviral therapy for moderate to severe COVID-19. Although remdesivir was the first drug approved for COVID-19, information about its efficacy and safety profile is limited in a significant segment of the population

Reactive Infectious Mucocutaneous Eruptions (RIME) in COVID-19

Date
Friday, January 05, 2024 - 4:00 AM
Description
Reactive infectious mucocutaneous eruptions (RIME) is a relatively novel terminology describing postinfectious mucocutaneous eruptions that usually affect 2 or more mucosal sites. To our knowledge, we describe the first case of RIME secondary to

Regulation of innate immune and inflammatory responses by supersulfides

Date
Friday, January 05, 2024 - 4:00 AM
Description
Innate immunity plays an important role in host defense against microbial infections. It also participates in activation of acquired immunity through cytokine production and antigen presentation. Pattern recognition receptors such as Toll-like